Theophylline: new perspectives for an old drug

Am J Respir Crit Care Med. 2003 Mar 15;167(6):813-8. doi: 10.1164/rccm.200210-1142PP.
No abstract available

Publication types

  • Review

MeSH terms

  • Apoptosis / drug effects
  • Asthma / drug therapy*
  • Asthma / immunology
  • Asthma / metabolism
  • Bronchodilator Agents / immunology
  • Bronchodilator Agents / pharmacology
  • Bronchodilator Agents / therapeutic use*
  • Gene Expression / drug effects
  • Gene Expression / immunology
  • Histone Deacetylases / drug effects
  • Histone Deacetylases / immunology
  • Humans
  • Inflammation / immunology
  • Interleukin-10 / immunology
  • Metabolic Clearance Rate
  • Molecular Biology
  • Patient Selection
  • Phosphodiesterase Inhibitors / immunology
  • Phosphodiesterase Inhibitors / pharmacology
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Practice Guidelines as Topic
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Pulmonary Disease, Chronic Obstructive / metabolism
  • Receptors, Purinergic P1 / drug effects
  • Theophylline / immunology
  • Theophylline / pharmacology
  • Theophylline / therapeutic use*
  • Transcription, Genetic / drug effects

Substances

  • Bronchodilator Agents
  • Phosphodiesterase Inhibitors
  • Receptors, Purinergic P1
  • Interleukin-10
  • Theophylline
  • Histone Deacetylases